ICD-10-CM Billable Code

E85.9

Amyloidosis, unspecified

Clinical Classification Guidelines

Medical Intelligence & Overview

Amyloidosis is a rare condition characterized by the abnormal buildup of amyloid proteins in various tissues and organs of the body. When this accumulation occurs without a specified type or cause, it is classified under ICD-10 code E85.9, known as unspecified amyloidosis. This buildup can interfere with normal organ function and lead to a range of health issues, depending on which organs are affected.

Causes & Symptoms

Clinical Causes: Idiopathic factors, where the cause is unknown Chronic inflammatory conditions Genetic mutations that affect protein production Infections, such as tuberculosis or leprosy Chronic diseases like rheumatoid arthritis Certain blood cancers, such as multiple myeloma Other plasma cell disorders

Key Symptoms: Swelling or enlarged organs, especially the liver, spleen, or heart Fatigue and weakness Unexplained weight loss Shortness of breath or irregular heartbeat if the heart is involved Numbness or tingling in limbs if nerves are affected Skin changes like purplish or waxy patches Diabetes-like symptoms if pancreatic involvement occurs Digestive issues such as diarrhea or difficulty swallowing

Diagnostic & Treatment

Diagnosis Path: Diagnosing amyloidosis often involves a combination of medical history review, physical examination, and specialized tests. These can include blood and urine tests to detect abnormal proteins, imaging studies like echocardiograms to assess organ function, and tissue biopsies to confirm amyloid deposits. Advanced techniques such as Congo red staining under polarized light are used to identify amyloid proteins in tissue samples. The exact type of amyloidosis may require additional molecular testing.

Treatment Protocols: While there is no universal cure for amyloidosis, treatment focuses on managing symptoms and slowing disease progression. Approaches may include chemotherapy or targeted therapies to reduce abnormal protein production, supportive care to manage organ-specific issues, and in some cases, stem cell transplant. The treatment strategy often depends on the severity and organs involved, as well as the underlying cause, if identified.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is E85.9 a billable ICD-10 code?
Yes, E85.9 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report E85.9?
Clinical documentation must specify the nature of Amyloidosis, unspecified and any associated comorbidities for accurate reporting.

Cite this Clinical Reference